Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020 Jul 28, 2020 12:33PM
Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020 Jul 28, 2020 12:33PM
Eloxx Pharmaceuticals to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8th, 2019 Jul 17, 2019 07:30AM
Eloxx Pharmaceuticals to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8th, 2019 Jul 17, 2019 07:30AM
Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference Jul 18, 2018 07:30AM


Jul 18, 2018 07:30AM Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference
Jun 29, 2018 05:35AM Canaccord Genuity Starts Eloxx Pharma (ELOX) at Buy, 'Lead read-through therapeutic candidate ELX-02 promising'
Apr 30, 2018 04:01PM Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Apr 30, 2018 04:01PM Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Apr 26, 2018 05:55AM Eloxx Pharmaceuticals, Inc. (ELOX) Prices 5.13M Share Common Offering at $9.75/Sh
Apr 25, 2018 06:22PM Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
Apr 25, 2018 06:22PM Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
Apr 25, 2018 05:46AM Eloxx Pharmaceuticals, Inc. (ELOX) Announced Proposed 5M Share Common Offering (Yesterday)
Apr 24, 2018 04:01PM Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock